Innovative Medical Management Co Ltd (002173) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innovative Medical Management Co Ltd (002173) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-12.00 Million ≈ $-1.76 Million USD) by net assets (CN¥1.79 Billion ≈ $261.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Innovative Medical Management Co Ltd (002173) balance sheet quality index to measure how much of total assets are equity-financed.
Innovative Medical Management Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Innovative Medical Management Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002173 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Innovative Medical Management Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innovative Medical Management Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Teva Pharmaceutical Industries Ltd
TA:TEVA
|
0.038x |
|
Jinhui Liquor Co Ltd
SHG:603919
|
-0.011x |
|
Kestra Medical Technologies, Ltd. Common Stock
NASDAQ:KMTS
|
-0.064x |
|
Adriatic Metals Plc
F:3FN
|
-0.035x |
|
Beijing Sanju Environmental
SHE:300072
|
0.033x |
|
Asian Star Anchor Chain Co Ltd Jiangsu
SHG:601890
|
-0.008x |
|
Heidrick & Struggles International
NASDAQ:HSII
|
0.264x |
|
Shanghai Jinqiao Export Processing Zone Development Co Ltd A
SHG:600639
|
0.007x |
Annual Cash Flow Conversion Efficiency for Innovative Medical Management Co Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Innovative Medical Management Co Ltd from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see 002173 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.78 Billion ≈ $260.05 Million |
CN¥-7.34 Million ≈ $-1.07 Million |
-0.004x | -170.10% |
| 2023-12-31 | CN¥1.87 Billion ≈ $273.80 Million |
CN¥11.03 Million ≈ $1.61 Million |
0.006x | +145.95% |
| 2022-12-31 | CN¥1.91 Billion ≈ $278.80 Million |
CN¥-24.45 Million ≈ $-3.58 Million |
-0.013x | -158.90% |
| 2021-12-31 | CN¥1.99 Billion ≈ $291.33 Million |
CN¥43.37 Million ≈ $6.35 Million |
0.022x | -64.52% |
| 2020-12-31 | CN¥2.14 Billion ≈ $313.80 Million |
CN¥131.67 Million ≈ $19.27 Million |
0.061x | +57.36% |
| 2019-12-31 | CN¥2.47 Billion ≈ $361.43 Million |
CN¥96.37 Million ≈ $14.10 Million |
0.039x | +9.02% |
| 2018-12-31 | CN¥3.62 Billion ≈ $529.21 Million |
CN¥129.44 Million ≈ $18.94 Million |
0.036x | -36.52% |
| 2017-12-31 | CN¥3.66 Billion ≈ $534.98 Million |
CN¥206.12 Million ≈ $30.16 Million |
0.056x | -20.40% |
| 2016-12-31 | CN¥3.53 Billion ≈ $516.83 Million |
CN¥250.18 Million ≈ $36.61 Million |
0.071x | -12.63% |
| 2015-12-31 | CN¥413.37 Million ≈ $60.49 Million |
CN¥33.51 Million ≈ $4.90 Million |
0.081x | +264.48% |
| 2014-12-31 | CN¥478.62 Million ≈ $70.04 Million |
CN¥10.65 Million ≈ $1.56 Million |
0.022x | +161.34% |
| 2013-12-31 | CN¥501.53 Million ≈ $73.39 Million |
CN¥4.27 Million ≈ $624.65K |
0.009x | -84.81% |
| 2012-12-31 | CN¥520.22 Million ≈ $76.12 Million |
CN¥29.16 Million ≈ $4.27 Million |
0.056x | +374.08% |
| 2011-12-31 | CN¥466.02 Million ≈ $68.19 Million |
CN¥-9.53 Million ≈ $-1.39 Million |
-0.020x | -193.58% |
| 2010-12-31 | CN¥434.36 Million ≈ $63.56 Million |
CN¥9.49 Million ≈ $1.39 Million |
0.022x | +122.54% |
| 2009-12-31 | CN¥403.89 Million ≈ $59.10 Million |
CN¥-39.15 Million ≈ $-5.73 Million |
-0.097x | +36.38% |
| 2008-12-31 | CN¥391.58 Million ≈ $57.30 Million |
CN¥-59.67 Million ≈ $-8.73 Million |
-0.152x | +45.44% |
| 2007-12-31 | CN¥349.87 Million ≈ $51.20 Million |
CN¥-97.73 Million ≈ $-14.30 Million |
-0.279x | -1169.27% |
| 2006-12-31 | CN¥134.18 Million ≈ $19.63 Million |
CN¥3.50 Million ≈ $512.88K |
0.026x | +103.64% |
| 2005-12-31 | CN¥102.34 Million ≈ $14.98 Million |
CN¥-73.50 Million ≈ $-10.76 Million |
-0.718x | -1035.23% |
| 2004-12-31 | CN¥82.10 Million ≈ $12.01 Million |
CN¥-5.19 Million ≈ $-760.10K |
-0.063x | -- |
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, and physical examination services. The company was formerly known as Qianzu Pearl Group Co., Ltd. and changed its name to Innovative Medical Management Co.,Ltd. in Ju… Read more